Correspondence 0001213900-23-018671 from Incannex Healthcare Inc. (IXHL)
Incannex Healthcare Inc.
Date: March 9, 2023 · CIK: 0001873875 · Accession: 0001213900-23-018671
AI Filing Summary & Sentiment
File numbers found in text: 333-270218
Letter
Incannex Healthcare Limited
Suite 105, 8 Century Circuit
Norwest, NSW 2153
Australia
March 9, 2023
via EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
RE: Incannex Healthcare Limited
Registration Statement on Form F-3
Filed: March 2, 2023
Securities Act File No. 333-270218
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, Incannex Healthcare Limited (the “Registrant”) hereby respectfully requests acceleration of its Registration Statement on Form F-3 (File No. 333-270218), filed on March 2, 2023, so that it will become effective at 10:00 a.m. (Eastern time) on March 13, 2023, or as soon as practicable thereafter.
If you have any questions, or require any additional information, please do not hesitate to email Andrew Reilly, the Registrant’s outside counsel, at andrew.reilly@rimonlaw.com.
The Registrant hereby acknowledges that, if the Securities and Exchange Commission (or its staff, acting pursuant to delegated authority) (the “Commission”) declares the filing effective, such action:
(i) does not foreclose the Commission from taking any action with respect to the filing;
(ii) does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
(iii)
may not be asserted by the Registrant as a defence in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Very truly yours,
Incannex Healthcare Limited
Show Raw Text
CORRESP
1
filename1.htm
Incannex Healthcare Limited
Suite 105, 8 Century Circuit
Norwest, NSW 2153
Australia
March 9, 2023
via EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
RE:
Incannex Healthcare Limited
Registration Statement on Form F-3
Filed: March 2, 2023
Securities Act File No. 333-270218
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities
Act of 1933, Incannex Healthcare Limited (the “Registrant”) hereby respectfully requests acceleration of its Registration
Statement on Form F-3 (File No. 333-270218), filed on March 2, 2023, so that it will become effective at
10:00 a.m. (Eastern time) on March 13, 2023, or as soon as practicable thereafter.
If you have any questions, or require any
additional information, please do not hesitate to email Andrew Reilly, the Registrant’s outside counsel, at andrew.reilly@rimonlaw.com.
The Registrant hereby acknowledges that, if
the Securities and Exchange Commission (or its staff, acting pursuant to delegated authority) (the “Commission”) declares
the filing effective, such action:
(i) does
not foreclose the Commission from taking any action with respect to the filing;
(ii) does
not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
(iii)
may not be asserted by the Registrant as a defence in any proceeding
initiated by the Commission or any person under the federal securities laws of the United States.
Very truly yours,
Incannex Healthcare Limited
By:
/s/ Joel Latham
Joel Latham
Chief Executive Officer and Managing Director